Aspen Aerogels (NYSE:ASPN) Sets New 1-Year Low – Should You Sell?

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $7.17 and last traded at $7.19, with a volume of 2130869 shares traded. The stock had previously closed at $7.61.

Wall Street Analyst Weigh In

ASPN has been the topic of several research analyst reports. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research note on Wednesday, February 19th. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Barclays decreased their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday, February 19th. Finally, Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.44.

Aspen Aerogels Price Performance

The stock has a market capitalization of $589.92 million, a PE ratio of 44.94 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The stock’s fifty day moving average is $11.06 and its 200-day moving average is $17.40.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds have recently bought and sold shares of ASPN. Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $89,000. AlphaQuest LLC raised its position in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after acquiring an additional 3,998 shares during the period. KLP Kapitalforvaltning AS purchased a new position in Aspen Aerogels during the fourth quarter valued at $164,000. Connors Investor Services Inc. acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at about $168,000. Finally, Journey Strategic Wealth LLC purchased a new stake in shares of Aspen Aerogels during the fourth quarter worth about $178,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.